Terpyridine platinum compounds induce telomere dysfunction and chromosome instability in cancer cells.

Petrov, Nikolai; Lee, Hee-Sheung; Liskovykh, Mikhail; Teulade-Fichou, Marie-Paule; Masumoto, Hiroshi; Earnshaw, William C; Pommier, Yves; Larionov, Vladimir; Kouprina, Natalay.

Petrov N; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Lee HS; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Liskovykh M; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Teulade-Fichou MP; Chemistry and Modelling for the Biology of Cancer, CNRS UMR 9187-INSERM U1196 Institute Curie, Research Center, Campus University Paris-Saclay, Orsay, France.
Masumoto H; Laboratory of Chromosome Engineering, Department of Frontier Research and Development, Kazusa DNA Research Institute, Kisarazu, Chiba 292-0818, Japan.
Earnshaw WC; Wellcome Centre for Cell Biology, School of Biological Sciences, King's Buildings, University of Edinburgh, Max Born Crescent, Edinburgh EH9 3BF, Scotland.
Pommier Y; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Larionov V; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Kouprina N; Developmental Therapeutics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.